Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 2
2002 4
2003 4
2004 2
2005 5
2006 2
2007 3
2008 7
2009 4
2010 2
2011 6
2012 9
2013 13
2014 5
2015 7
2016 14
2017 11
2018 5
2019 12
2020 14
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Abdelhamid A, Davey Smith G. Hooper L, et al. Cochrane Database Syst Rev. 2015 Jun 10;(6):CD011737. doi: 10.1002/14651858.CD011737. Cochrane Database Syst Rev. 2015. PMID: 26068959 Updated. Review.
Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Hooper L, et al. Cochrane Database Syst Rev. 2020 May 19;5(5):CD011737. doi: 10.1002/14651858.CD011737.pub2. Cochrane Database Syst Rev. 2020. PMID: 32428300 Free PMC article. Updated.
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S, Granger CB, Held C, Wallentin L, Alexander JH, Lopes RD. Garcia DA, et al. Am Heart J. 2020 Mar;221:1-8. doi: 10.1016/j.ahj.2019.10.013. Epub 2019 Oct 31. Am Heart J. 2020. PMID: 31896036 Clinical Trial.
Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Hooper L, et al. Cochrane Database Syst Rev. 2020 Aug 21;8(8):CD011737. doi: 10.1002/14651858.CD011737.pub3. Cochrane Database Syst Rev. 2020. PMID: 32827219
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, Huber K, Jansky P, Steg PG, Hanna M, Thomas L, Wallentin L, Granger CB. Hylek EM, et al. J Am Coll Cardiol. 2014 May 27;63(20):2141-2147. doi: 10.1016/j.jacc.2014.02.549. Epub 2014 Mar 19. J Am Coll Cardiol. 2014. PMID: 24657685 Free article. Clinical Trial.
112 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page